Actively Recruiting
National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa
Led by North-West University, South Africa · Updated on 2026-04-07
22464
Participants Needed
11
Research Sites
243 weeks
Total Duration
On this page
Sponsors
N
North-West University, South Africa
Lead Sponsor
M
Medical Research Council, South Africa
Collaborating Sponsor
AI-Summary
What this Trial Is About
The Childhood Hypertension Consortium of South Africa (CHCSA) was established to foster relationships between the healthcare sector and schools through community engagement and outreach as well as contributing to the decolonization of normative paediatric blood pressure reference values. To date, there has been no nation-wide project in South Africa to determine nationally representative normal blood pressure reference values, nor to estimate the true prevalence of hypertension in the paediatric population of the country. This study will provide critical information on the understanding of blood pressure and hypertension in children, especially of African ancestry. Not only will this effort contribute to the development of the first nationally representative normal reference values of blood pressure but will also benefit healthcare providers in the sector with a clear guideline on the management of high blood pressure in children as developed by experts working with these challenges daily.
CONDITIONS
Official Title
National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children between 5 and under 18 years old
- Voluntary assent from the child and permission from a parent or guardian
You will not qualify if you...
- Inability to give informed consent due to comprehension or language barriers
- Children who do not assent or whose parents do not consent to participate
- Use of drugs, alcohol, or tobacco products that interfere with study participation
- Age under 5 years or 18 years and older
- Use of medications or presence of diseases (e.g., chronic kidney or heart disease) that affect blood pressure, leading to exclusion from analysis for normative values
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
Walter Sisulu University
Mthatha, Eastern Cape, South Africa
Not Yet Recruiting
2
Nelson Mandela Metropolitan University
Port Elizabeth, Eastern Cape, South Africa
Actively Recruiting
3
University of the Free State
Bloemfontein, Free State, South Africa
Actively Recruiting
4
University of the Witwatersrand
Johannesburg, Gauteng, South Africa
Actively Recruiting
5
University of KwaZulu-Natal
Durban, KwaZulu-Natal, South Africa
Not Yet Recruiting
6
University of Limpopo
Polokwane, Limpopo, South Africa
Not Yet Recruiting
7
Hypertension in Africa Research Team (HART), North-West University
Potchefstroom, North West, South Africa, 2531
Actively Recruiting
8
Red Cross War Memorial Children Hospital
Cape Town, Western Cape, South Africa
Not Yet Recruiting
9
South African Medical Research Council
Cape Town, Western Cape, South Africa
Not Yet Recruiting
10
University of Cape Town
Cape Town, Western Cape, South Africa
Not Yet Recruiting
11
University of Zurich
Zurich, Switzerland
Not Yet Recruiting
Research Team
R
Ruan Kruger, PhD
CONTACT
L
Lebo F Gafane-Matemane, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here